Press release
Sjögren’s Syndrome Market Segment Analysis By Eisai Co., Ltd.,., Novartis AG, AstraZeneca, Genentech, Inc., Nicox, ALLERGAN, Biogen
Sjögren’s Syndrome Market
Global Sjögren’s Syndrome Market By Type (Primary Sjögren’s Syndrome, Secondary Sjögren’s Syndrome), Symptoms (Dry Eyes, Dry Mouth, Others), Diagnosis (Blood Tests, Eye Tests, Lip Biopsy, Others), Treatment (Medication, Surgery, Others), Drugs (Salagen, Evoxac, Plaquenil, Others), End Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast to 2027
Get Exclusive Sample Copy of this Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-sjgrens-syndrome-market
Few of the major competitors currently working in the global Sjögren’s syndrome market are Advanz Pharmaceutical, Eisai Co., Ltd.,., Novartis AG, AstraZeneca, Genentech, Inc., Nicox, ALLERGAN, Biogen, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, Amgen Inc., Lupin, Kissei Pharmaceutical Co., Ltd., Pfizer Inc., Santen Pharmaceutical Co., Ltd., Bausch Health, Resolve Therapeutics, Wize Pharma Inc. among others.
Market Definition:
Sjögren’s syndrome is an autoimmune disease that causes dryness of the mouth and eyes. This syndrome is associated with other immune system disorders such as rheumatoid arthritis and lupus. The major symptoms of this syndrome are dryness in eyes and mouth followed by joint pain, swollen salivary glands and others. There are two types of Sjogren’s syndromes i.e. primary Sjogren’s syndrome and secondary Sjogren’s syndrome.
The prevalence rate of Sjogren’s syndrome is estimated to be 0.1 to 4% of global population. The occurrence of this disease in women is 10 times higher than men. Sjogren’s syndrome can occur in any age group, but it is most common in age of 45 to 55 years.
Market Drivers
Increasing incidence of Sjogren’s syndrome and other autoimmune diseases are major drivers for the growth of market
Rise in geriatric population susceptible to autoimmune diseases will drive the market growth
Improvement in health care expenditure in many countries for the disease treatmnet will also boost the market growth in the forecast period
Strong drug pipeline present for the disease is another factor driving the market growth
Market Restraints
Unwanted immunogenicity caused by drugs used for treatment of Sjogren’s syndrome hampers the market growth
Lack of awareness about sjogren’s syndrome acts as restrain to the market growth
Lack of proper treatment of Sjogren’s syndrome is another factor which hinders the market growth
Avail Discount On this Report @ https://www.databridgemarketresearch.com/request-a-discount/global-sjgrens-syndrome-market
Segmentation: Global Sjögren’s Syndrome Market
By Type
Primary Sjögren’s Syndrome
Secondary Sjögren’s Syndrome
By Symptoms
Dry Eyes
Dry Mouth
Others
By Diagnosis
Blood Tests
Eye Tests
Lip Biopsy
Others
By Treatment
Medication
Surgery
Others
By Drugs
Salagen
Evoxac
Plaquenil
Others
By End Users
Hospitals
Homecare
Specialty Clinics
Others
By Distribution Channels
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Others
By Geography
North America
US.
Canada
Mexico
Europe
Germany
Italy
UK.
France
Spain
Netherlands
Belgium
Switzerland
Turkey
Russia
Hungary
Lithuania
Austria
Ireland
Norway
Poland
Rest of Europe
Asia-Pacific
Japan
China
India
South Korea
Australia
Singapore
Malaysia
Thailand
Indonesia
Philippines
Vietnam
Rest of Asia-Pacific
South America
Brazil
Argentina
Peru
Rest of South America
Middle East and Africa
South Africa
Saudi Arabia
UAE
Kuwait
Israel
Egypt
Rest of Middle East and Africa
Key Developments in the Market:
In May 2019, IntelGenx Corp. received the U. S. patent from the United States Patent and Trademark Office for design and manufacturing of topical oral films (TOF) for treatment of Sjögren’s syndrome and other conditions such as gingivitis, buccal ulcers and canker sores. This patent is entitled as “Film Dosage Form with Extended Release Mucoadhesive Particles.” This patent issue provides intellectual property rights to the company for manufacturing and marketing exclusivity of topical oral films (TOF)
In April 2019, Advanz Pharmaceutical acquired the global marketing rights of Salagen (pilocarpine hydrochloride) from Eisai Co., Ltd. Salagen is used for treatment of dry mouth in patients suffering from Sjögren’s syndrome. In this acquisition Advanz Pharmaceutical has received the marketing and commercialization approval of salagen worldwide except Japan
Competitive Analysis:
Global Sjögren’s syndrome market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Sjögren’s syndrome market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Reasons to Purchase this Report
Current and future of global Sjögren’s syndrome market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players
View Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-sjgrens-syndrome-market
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: Corporatesales@databridgemarketresearch.com
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Sjögren’s Syndrome Market Segment Analysis By Eisai Co., Ltd.,., Novartis AG, AstraZeneca, Genentech, Inc., Nicox, ALLERGAN, Biogen here
News-ID: 2140859 • Views: …
More Releases from Data Bridge Market Research
Water Treatment System Market: Sustaining the Future of Clean Water
Introduction
Understanding Water Treatment Systems
Water treatment systems are designed to purify and disinfect water for various uses-drinking, industrial processes, irrigation, and wastewater reuse. These systems eliminate contaminants such as bacteria, viruses, heavy metals, chemicals, and particulates, making water safe and sustainable for consumption and use.
Importance in Global Sustainability
Clean water is essential to life and industrial progress. With growing water demand and pollution, water treatment systems are now critical infrastructure across the…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
More Releases for Sjögren’s
WORLD SJOGREN'S DAY
World Sjögren’s Day - July 23
Chronic fatigue is associated with reduced quality of life
Chronic fatigue is one of the most common symptoms of Sjögren's and clearly differs from the usual fatigue according to Sjögren Europe. “We describe it as an incessant, fluctuating and unreliable lack of vitality that is beyond one's control. Not everyone experiences it the same way, but fatigue is undoubtedly a permanent part of patients'…
Global Sjogren’s Syndrome Acids Market Share: Global Trends, Key Players, Indu …
The global Sjogren’s syndrome market is anticipated to grow at a CAGR of 4.6% during the forecast period (2021-2027). The factors contributing to the growth of the market include rising Sjogren’s syndrome and other autoimmune diseases. For instance, according to the American College of Rheumatology, in a large US observational registry, out of a total of 24,528 patients, 7870 (31.2%) were found to be diagnosed with Sjogren’s syndrome. It was…
Sjögren’s Syndrome Market Key Country Analysis: Advanz Pharmaceutical, Eisai …
Sjögren’s Syndrome Market By Type (Primary Sjögren’s Syndrome, Secondary Sjögren’s Syndrome), Symptoms (Dry Eyes, Dry Mouth, Others), Diagnosis (Blood Tests, Eye Tests, Lip Biopsy, Others), Treatment (Medication, Surgery, Others), Drugs (Salagen, Evoxac, Plaquenil, Others), End Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast to 2027 Global Sjögren’s syndrome market is…
Sjögren’s Syndrome Therapeutics - Pipeline, Key Players Analysis UCB, Bristol …
The study analyzed that Sjögren’s syndrome pipeline comprises of approximately 42 drug candidates in different stages of development.
Sjögren’s syndrome is a chronic inflammatory disease, which leads to infiltration of lacrimal and salivary glands. It is mostly associated with sicca symptoms, which include dry eyes (xeropthalmia) and dry mouth (xerostomia). It is also associated with other autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis. The treatment approaches for this…
Anti-Nuclear Antibody (ANA) Test Market 2018 Leaders Analysis: Alere Inc., Bio-R …
The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.Anti-Nuclear Antibody (ANA) Test Market report provides an outlook for current market value as well as the expected growth of Anti-Nuclear Antibody (ANA) Test during 2018-2025. The whole supply chain of Anti-Nuclear Antibody (ANA) Test has been explained with statistical details with a special emphasis on…
Sjögren’s Syndrome Therapeutics Pipeline Analysis, 2017
The study analyzed that Sjögren’s syndrome pipeline comprises of approximately 42 drug candidates, of which 29 drug candidates are in active stage. Among the active drug candidates, three are in Phase III stage, 10 are in Phase II stage, seven are in Phase I stage and nine are in Pre-Clinical stage. The development of 11 Sjögren’s syndrome drug candidates is found to be inactive and two drug candidates are discontinued.
Browse…
